User:IncretinIvo
Editor·15,723 edits·since 2024/07
IncretinIvo is an editor on PeptidePedia Wiki, editing since 2024 / 7.
This editor works mainly on incretin biology and receptor pharmacology. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
15,723Total edits
25Logged here
16Articles touched
2024/07Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is incretin biology and receptor pharmacology.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Incretin effect | 5 | 78 | 6% |
| Glucagon-like peptide-1 | 3 | 90 | 3% |
| Glucose-dependent insulinotropic polypeptide | 3 | 74 | 4% |
| Syringe dead space | 1 | 70 | 1% |
| Hubei Jianxiang Bioscience | 1 | 61 | 2% |
| Reconstitution calculator | 1 | 70 | 1% |
| Karl Fischer titration | 1 | 82 | 1% |
| Shanghai ERP Biotechnology | 1 | 74 | 1% |
| Trial data comparison | 1 | 78 | 1% |
| Multi-dose vial | 1 | 70 | 1% |
| Enteroendocrine L cell | 1 | 66 | 2% |
| Sangon Biotech | 1 | 70 | 1% |
| Peptide stability table | 1 | 74 | 1% |
| Xi'an Mokemei Biotechnology | 1 | 74 | 1% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.